CoChat

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Avoiding the immune rejection of transplanted T cells is central to the success of allogeneic cancer immunotherapies. One solution to protecting T-cell grafts from immune rejection involves the deletion of allogeneic factors and of factors that activate cytotoxic immune cells. Here we report the generation of hypoimmunogenic cancer-antigen-specific T cells derived from induced pluripotent stem cells (iPSCs) lacking β 2-microglobulin, the class-II major histocompatibility complex (MHC) transactivator and the natural killer (NK) cell-ligand poliovirus receptor CD155, and expressing single-chain MHC class-I antigen E. In mouse models of CD20-expressing leukaemia or lymphoma, differentiated T cells expressing a CD20 chimeric antigen receptor largely escaped recognition by NKG2A+ and DNAM-1+ NK cells and by CD8 and CD4 T cells in the allogeneic recipients while maintaining anti-tumour potency. Hypoimmunogenic iPSC-derived T cells may contribute to the creation of off-the-shelf T cell immunotherapies.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41551-021-00730-z

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. King, A. et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30, 1623–1631 (2000). · doi:10.1002/1521-4141(200006)30:6<1623::aid-immu1623>3.0.co;2-m

Cited by

See all 191

Metadata

Authors
Wang, B., Iriguchi, S., Waseda, M., Ueda, N., Ueda, T., Xu, H., Minagawa, A., Ishikawa, A., Yano, H., Ishi, T., Ito, R., Goto, M., Takahashi, R., Uemura, Y., Hotta, A., & Kaneko, S.
Affiliations
  • Kyoto University (JP)
  • Central Institute for Experimental Animals (JP)
  • National Cancer Center Hospital East (JP)
Corresponding author
Kaneko, Shin
Venue
Nature Biomedical Engineering
Published
2021-05-17
Volume
5
Issue
5
Pages
429-440
ISSN
2157-846X (ISSN-L)
OpenAlex
W3160669634
Cited by
189
References
53
Citations by year
2026: 29 · 2025: 31 · 2024: 60 · 2023: 51 · 2022: 13 · 2021: 5
FWCI
10.38
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Biomedical Engineering (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • MEXT | Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
induced pluripotent stem cells, immune rejection, MHC class I, CD155, NKG2A, DNAM-1, natural killer cells, off-the-shelf T cell therapy, leukemia, lymphoma
MeSH terms
T Lineage-Specific Activation Antigen 1, Animals, Antigens, Differentiation, T-Lymphocyte, beta 2-Microglobulin, Cell Differentiation, Cell Line, Genetic Engineering, Humans, Leukemia, Lymphoma, Male, Receptors, Virus, T-Lymphocytes, Xenograft Model Antitumor Assays, Mice, NK Cell Lectin-Like Receptor Subfamily C, Gene Knockout Techniques, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. https://app.cochat.ai/papers/10.1038/s41551-021-00730-z
The paper
Wang, B., Iriguchi, S., Waseda, M., Ueda, N., Ueda, T., Xu, H., Minagawa, A., Ishikawa, A., Yano, H., Ishi, T., Ito, R., Goto, M., Takahashi, R., Uemura, Y., Hotta, A., & Kaneko, S. (2021). Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-021-00730-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.